http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1720642_PMID32631509

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461536083_AID1720642_PMID32631509_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103188975_AID1720642_PMID32631509_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461518849_AID1720642_PMID32631509_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID440190569_AID1720642_PMID32631509_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461543602_AID1720642_PMID32631509_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461524881_AID1720642_PMID32631509_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461522495_AID1720642_PMID32631509_VALUE4
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Fold resistance, ratio of EC50 for inhibition of reverse transcriptase K103N/Y181C double mutant/nucleocapsid protein 7 in HIV1 RES056 infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay to EC50 for reverse transcriptase/nucleocapsid protein 7 in wild type HIV1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathic effect incubated for 5 days by MTT assay
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461536083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461522495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103188975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461518849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461524881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461543602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID440190569
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1720642

Total number of triples: 18.